Global platelet aggregation devices market size to reach US 1,556.8 million by 2027

Description: The latest report on ‘global platelet aggregation devices market’ encompasses an exhaustive analysis of this business sphere, inclusive of historical data, qualitative insights, and verifiable projections for 2020-2027. It highlights the factors positively or negatively impacting the market dynamics, and also lists out the opportunities which can be exploited for strong profits in the forthcoming years.

According to industry experts, worldwide platelet aggregation devices market is expected to record a healthy growth rate during 2020-2027, subsequently accumulating USD 1,556.8 million by the end of the forecast period. Growing prevalence of blood disorders and chronic ailments is the primary growth driver of the industry. However, in recent times, the market is largely driven by the upsurge in cases of infectious diseases, particularly Covid-19 which requires rapid serological tests.

The research document provides a broad understanding of the industry ecosystem across the various geographies, uncovering the promising areas falling under North America, Europe, Latin America, APAC, and MEA. It further segments the industry in terms of product type, application spectrum, and end-user scope, followed by individual assessment of the same. It then proceeds to deduce the competitive hierarchy of the leading players. Additionally, the study incorporates the key changes in the marketplace triggered by the COVID-19 outbreak. 

For those unfamiliar, platelet aggregating is a biological process wherein platelet cells clump together for rapid clot formations so as to prevent bleeding through vasoconstrictions. Platelet aggregating factor or PAF-acether acts a mediator for catalyzing the aggregation process. Qualitative and quantitative flaws of platelets are responsible for increased bleeding.  

Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/2963826/

Platelet function related disorders are either inherited or acquired. Von Willebrand disease, Glanzmann's thrombasthenia, Bernard-Soulier syndrome, and Storage pool disease are inherited disorders. Whereas, acquired platelet dysfunctions are caused due to chronic conditions such as Myelodysplastic syndrome (MDS), kidney failure (uremia), chronic myeloid leukemia, and acute myeloid leukemia.

Owing to emergence of anti-platelet medications, tricyclic antidepressants, non-steroidal anti-inflammatory drugs (NSAIDs), antihistamines, and some antibiotics which reduce platelet function, some acquired platelet disorders are temporary. Hence, the scope of platelet function testing has extended multifold, and ultimately accelerated overall platelet aggregation devices market expansion.

Furthermore, automation of systems is likely to present new growth opportunities in the upcoming years. In fact, automated haematology analyzers which can determine platelet counts over a wide range of values using optical counting methods, and screening tests like activated partial thromboplastin time (aPTT) or prothrombin time (PT) that are fully automated are actively being utilized in the industry. Apart from this, availability of numerous reagents in the market for performing platelet function tests, including collagen, ADP, thrombin, epinephrine, vasopressin, and ristocetin, have positively impacted global platelet aggregation devices industry outlook.

To access a sample pages of this report titled “Platelet Aggregation Devices Market Share, Size, Trends, Industry Analysis Report, By Product (Systems, Reagents, Consumables and Accessories); By Application (Research Applications, Clinical Applications, Others); By End Use (Standalone Hospitals, Diagnostic Laboratories, Research and Academic Institutes, Blood Banks, and Other End Users); By Regions; Segment Forecast, 2020 -2027” in detail along with the table of contents, please click the link below:

https://www.marketstudyreport.com/reports/platelet-aggregation-devices-market-share-size-trends-industry-analysis-report-by-product-systems-reagents-consumables-and-accessories-by-application-research-applications-clinical-applications-others-by-end-use-standalone-hospitals-diagnostic-laboratories-research-and-academic-institutes-blood-banks-and-other-end-users-by-regions-segment-forecast-2020-2027

Global Platelet Aggregation Devices Product Gamut (Revenue, USD Million, 2016 - 2027)

  • Reagents
  • Systems
  • Consumables and Accessories

Global Platelet Aggregation Devices Application Spectrum (Revenue, USD Million, 2016 - 2027)

  • Clinical Applications
  • Research Applications
  • Others

Global Platelet Aggregation Devices End-User Scope (Revenue, USD Million, 2016 - 2027)

  • Standalone Hospitals
  • Research and Academic Institutes
  • Diagnostic Laboratories
  • Blood Banks
  • Others

Global Platelet Aggregation Devices Regional Bifurcation (Revenue, USD Million, 2016 - 2027)

North America

  • United States
  • Canada

Europe

  • United Kingdom
  • Germany
  • Italy
  • France
  • Spain
  • Netherlands
  • Austria

Asia Pacific

  • China
  • India
  • Malaysia
  • Japan
  • South Korea
  • Indonesia

Middle East & Africa

  • Saudi Arabia
  • UAE
  • Israel
  • South Africa

Latin America

  • Mexico
  • Brazil
  • Argentina

Global Platelet Aggregation Devices Market Company Profiles (Revenue, USD Million, 2016-2027)

  • Sienco, Inc.
  • Aggredyne, Inc.
  • Sentinel CH. S.p.A
  • Helena Laboratories Corp.
  • Accriva Diagnostics Holdings, Inc.
  • Siemens Healthineers AG
  • Sysmex Corp.
  • Haemonetics Corp.
  • Drucker Diagnostics, Inc.
  • F. Hoffmann La-Roche AG

Related Report:

Platelet and Plasma Market Size By, Industry Analysis Report, Regional Outlook, Application Potential, Growth Potential, Price Trend, Competitive Market Share & Forecast, 2020 - 2026

The platelet and plasma market is set to record considerable growth in coming years due to the increasing occurrence of chronic diseases across the globe. In modern day medical therapies, patients can receive either a pint of complete blood or just specific components present within the blood that are essential to treat particular conditions. This treatment approach, known as a blood component treatment, enables several patients to receive more benefit from a single pint of the donated whole blood. Regionally, the LATAM market held a market value of over $460 million in 2019, owing to the growing incidence of hemophilia, autoimmune disorder, as well as other infectious diseases.

About US:

Market Study Report, LLC. is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.

Contact Us:

 
Corporate Sales,
Market Study Report LLC
Phone: 1-302-273-0910
Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com

News: http://business-newsupdate.com/

Back to news